跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CITALOPRAM-WGR citalopram (as hydrobromide) 40 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
CITALOPRAM-WGR citalopram (as hydrobromide) 40 mg tablet bottle
Approved
STANDARD
CITALOPRAM-WGR citalopram (as hydrobromide) 40 mg tablet bottle
GM Pharma International Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
e609eb23eab5c8a8
Company
GM Pharma International Pty Ltd
Type
Standard
Approval Details
Approval Id
e609eb23eab5c8a8
Product Name
CITALOPRAM-WGR citalopram (as hydrobromide) 40 mg tablet bottle
Artg Id
441515
Artg Name
CITALOPRAM-WGR citalopram (as hydrobromide) 40 mg tablet bottle
Sponsor
GM Pharma International Pty Ltd
Company Detail Path
/organization/gm-pharma-international-pty-ltd
Artg Date
2024-08-02
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
e609eb23eab5c8a8
Type
Standard
Back to TGA Approvals
